Daniil Gataulin

Chardan Capital | Healthcare

Daniil Gataulin is an analyst from Chardan Capital specializing in the Healthcare sector. Ranked #277 out of 4490 analysts, they have issued 64 stock ratings with a success rate of 83.28% and an average return of 55.38%.

Daniil Gataulin has a well-established track record, with 64 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 83.28% and an average return of 55.38%, underscoring their expertise and ability to identify winning opportunities for investors.

#277

Out of 4490

64

Total Ratings

+83.28%

Success Rate

+55.38%

Average Return

Recent Ratings Analysis

ANNX

Dec 23, 2025

Target

$16.00

Current

$5.19

Performance

%

Daniil Gataulin rated ANNX as Buy on Dec 23, 2025, setting a price target of 16. Shares have remained stable near 5.19, leaving the 16 target still in play.

KLRS

Dec 23, 2025

Target

$19.00

Current

$10.06

Performance

%

On Dec 23, 2025, KLRS was given a Buy rating by Daniil Gataulin, with a target price of 19. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

OCUL

Dec 09, 2025

Target

$21.00

Current

$12.96

Performance

-18.75%

OCUL received a Buy rating from Daniil Gataulin on Dec 09, 2025, aiming for 21. The rating hasn’t played out as hoped, with the stock trading 18.75% below expectations.

QURE

Dec 04, 2025

Target

$53.00

Current

$24.98

Performance

9.85%

On Dec 04, 2025, Daniil Gataulin published a Buy outlook on QURE, with a target of 53. Shares gained 9.85%, underscoring the accuracy of the bullish outlook toward 53.

RGNX

Nov 20, 2025

Target

$52.00

Current

$14.97

Performance

37.72%

Daniil Gataulin on Nov 20, 2025 assigned RGNX a Buy rating, with a price target of 52. The Buy call aligned well with market performance, producing a gain of 37.72%.

FBRX

Nov 17, 2025

Target

$61.00

Current

$29.33

Performance

102.42%

On Nov 17, 2025, Daniil Gataulin reaffirmed FBRX with a Buy rating, targeting 61. The recommendation was supported by strong follow-through as the stock rose from 29.33 to 29.33.

KOD

Nov 17, 2025

Target

$14.00

Current

$28.61

Performance

44.28%

KOD was rated Neutral by Daniil Gataulin on Nov 17, 2025, with a price objective of 14. Despite caution, upside momentum rewarded risk-takers with gains to 28.61.

ZURA

Nov 14, 2025

Target

$10.00

Current

$4.35

Performance

6.62%

On Nov 14, 2025, Daniil Gataulin initiated coverage on ZURA with a Buy rating and target of 10. The stock’s climb of 6.62% since the call highlights the foresight in the rating.

MGTX

Nov 14, 2025

Target

$35.00

Current

$8.30

Performance

1.34%

Daniil Gataulin issued a Buy recommendation for MGTX on Nov 14, 2025, price target set at 35. The target of 35 remains in play, though confirmation will depend on future moves.

IRD

Nov 13, 2025

Target

$9.00

Current

$2.06

Performance

11.35%

On Nov 13, 2025, IRD was evaluated by Daniil Gataulin, who gave a Buy rating and target of 9. This case illustrates how a timely bullish rating can translate into tangible gains of 11.35%.

OCS

Nov 11, 2025

Target

$51.00

Current

$20.35

Performance

4.90%

Daniil Gataulin rated OCS as Buy on Nov 11, 2025, setting a price target of 51. Shares have remained stable near 20.35, leaving the 51 target still in play.

OCGN

Sep 19, 2025

Target

$7.00

Current

$1.48

Performance

10.45%

On Sep 19, 2025, OCGN was given a Buy rating by Daniil Gataulin, with a target price of 7. The stock rallied 10.45% after the rating, narrowing the gap to the target of 7 and validating the bullish stance.

TRML

Sep 10, 2025

Target

$48.00

Current

$47.98

Performance

0.80%

TRML received a Neutral rating from Daniil Gataulin on Sep 10, 2025, aiming for 48. Shares remained flat at 47.98, aligning with the neutral rating.

OTLK

Aug 28, 2025

Target

$3.00

Current

$1.84

Performance

68.81%

On Aug 28, 2025, Daniil Gataulin published a Neutral outlook on OTLK, with a target of 3. The Hold call missed some of the bullish momentum as shares advanced toward 3.

ADVM

Aug 13, 2025

Target

$33.00

Current

$4.36

Performance

63.91%

Daniil Gataulin on Aug 13, 2025 assigned ADVM a Buy rating, with a price target of 33. The Buy call aligned well with market performance, producing a gain of 63.91%.

CRVO

Aug 11, 2025

Target

$15.00

Current

$8.12

Performance

-14.58%

On Aug 11, 2025, Daniil Gataulin reaffirmed CRVO with a Buy rating, targeting 15. Shares slid 14.58% despite the recommendation, highlighting downside risks.

CGTX

Aug 08, 2025

Target

$4.00

Current

$1.59

Performance

110.74%

CGTX was rated Buy by Daniil Gataulin on Aug 08, 2025, with a price objective of 4. A bullish response from the market helped close the gap of 2.41 to the target.

EYPT

Aug 07, 2025

Target

$27.00

Current

$18.85

Performance

87.19%

On Aug 07, 2025, Daniil Gataulin initiated coverage on EYPT with a Buy rating and target of 27. The stock’s climb of 87.19% since the call highlights the foresight in the rating.

CLSD

Jul 18, 2025

Target

$0.00

Current

$1.00

Performance

-83.70%

Daniil Gataulin issued a Neutral recommendation for CLSD on Jul 18, 2025, price target set at null. Market action validated the conservative Hold outlook with shares at 1.

UBX

Mar 25, 2025

Target

$4.00

Current

$0.20

Performance

-84.12%

On Mar 25, 2025, UBX was evaluated by Daniil Gataulin, who gave a Buy rating and target of 4. Investors saw limited payoff as shares fell short of the 4 target.

Frequency Asked Questions

Who is Daniil Gataulin?

Daniil Gataulin is an analyst from Chardan Capital specializing in the Healthcare sector.

What is Daniil Gataulin's success rate?

Daniil Gataulin currently has a success rate of +83.28%.

How many ratings has Daniil Gataulin issued?

Daniil Gataulin has issued 64 stock ratings so far.

What is the average return of Daniil Gataulin's calls?

Their stock ratings have generated an average return of +55.38%.

What is Daniil Gataulin's ranking?

Daniil Gataulin is ranked #277 out of 4490 analysts.

What types of ratings does Daniil Gataulin give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Daniil Gataulin?

You can follow Daniil Gataulin by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Daniil Gataulin?

Their latest rating was a Buy on ANNX issued on 2025-12-23.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep